Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials.
Publication
, Journal Article
Dzimitrowicz, HE; Armstrong, AJ
Published in: J Clin Oncol
March 10, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 10, 2022
Volume
40
Issue
8
Start / End Page
807 / 810
Location
United States
Related Subject Headings
- Quality of Life
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Male
- Humans
- Hormones
- Docetaxel
- Androstenes
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Dzimitrowicz, H. E., & Armstrong, A. J. (2022). Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials. J Clin Oncol, 40(8), 807–810. https://doi.org/10.1200/JCO.21.02504
Dzimitrowicz, Hannah E., and Andrew J. Armstrong. “Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials.” J Clin Oncol 40, no. 8 (March 10, 2022): 807–10. https://doi.org/10.1200/JCO.21.02504.
Dzimitrowicz HE, Armstrong AJ. Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials. J Clin Oncol. 2022 Mar 10;40(8):807–10.
Dzimitrowicz, Hannah E., and Andrew J. Armstrong. “Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials.” J Clin Oncol, vol. 40, no. 8, Mar. 2022, pp. 807–10. Pubmed, doi:10.1200/JCO.21.02504.
Dzimitrowicz HE, Armstrong AJ. Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials. J Clin Oncol. 2022 Mar 10;40(8):807–810.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 10, 2022
Volume
40
Issue
8
Start / End Page
807 / 810
Location
United States
Related Subject Headings
- Quality of Life
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Male
- Humans
- Hormones
- Docetaxel
- Androstenes
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis